ArticleCancer science2025

Cystathionine as a Potential Urinary Marker for Diagnosing and Assessing Pretreatment Risk in Neuroblastoma.

Hizuru Amano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.